Jessica Burket

Dr. Jessica Burket

Assistant Professor of Biology and Neuroscience, Department of Molecular Biology & Chemistry, Christopher Newport University, Avenue of the Arts, Newport News, VA 23606, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
JBJessica Burket
Jessica Burket
JWJason D. Webb
Jason D. Webb
SDStephen I. Deutsch
Stephen I. Deutsch
Because of their abilities to catalyze generation of toxic free radical species, free concentrations of the redox reactive metals iron and copper are highly regulated. Importantly, desired neurobiological effects of these redox reactive metal cations occur within very narrow ranges of their local concentrations. For example, synaptic release of free copper acts locally to modulate NMDA receptor-mediated neurotransmission. Moreover, within the developing brain, iron is critical to hippocampal maturation and the differentiation of parvalbumin-expressing neurons, whose soma and dendrites are surrounded by perineuronal nets (PNNs). The PNNs are a specialized component of brain extracellular matrix, whose polyanionic character supports the fast-spiking electrophysiological properties of these parvalbumin-expressing GABAergic interneurons. In addition to binding cations and creation of the Donnan equilibrium that support the fast-spiking properties of this subset of interneurons, the complex architecture of PNNs also binds metal cations, which may serve a protective function against oxidative damage, especially of these fast-spiking neurons. Data suggest that pathological disturbance of the population of fast-spiking, parvalbumin-expressing GABAergic inhibitory interneurons occur in at least some clinical presentations, which leads to disruption of the synchronous oscillatory output of assemblies of pyramidal neurons. Increased expression of the GluN2A NMDA receptor subunit on parvalbumin-expressing interneurons is linked to functional maturation of both these neurons and the perineuronal nets that surround them. Disruption of GluN2A expression shows increased susceptibility to oxidative stress, reflected in redox dysregulation and delayed maturation of PNNs. This may be especially relevant to neurodevelopmental disorders, including autism spectrum disorder. Conceivably, binding of metal redox reactive cations by the perineuronal net helps to maintain safe local concentrations, and also serves as a reservoir buffering against second-to-second fluctuations in their concentrations outside of a narrow physiological range.

22 January 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
SDStephen I. Deutsch
Stephen I. Deutsch
ZLZachary Norman Martin Luyo
Zachary Norman Martin Luyo
JBJessica Burket
Jessica Burket
Various ASD risk alleles have been associated with impairment of NMDA receptor activation (i.e., NMDA Receptor Hypofunction) and/or disturbance of the careful balance between activation mediated by GluN2B-subtype and GluN2A-subtype-containing NMDA receptors. Importantly, although these various risk alleles affect NMDA receptor activation through different mechanisms, they share the pathogenic consequences of causing disturbance of highly regulated NMDA receptor activation. Disturbances of NMDA receptor activation due to sequence variants, protein termination variants and copy number variants are often cell-specific and regionally selective. Thus, translational therapeutic NMDA receptor agonist interventions, which may require chronic administration, must have specificity, selectivity and facilitate NMDA receptor activation in a manner that is physiologic (i.e., mimicking that of endogenously released glutamate and glycine/D-serine released in response to salient and relevant socio-cognitive provocations within discrete neural circuits). Importantly, knockout mice with absent expression and mice with haploinsufficient expression of the deleterious genes often serve as good models to test the potential efficacy of promising pharmacotherapeutic strategies. The Review considers diverse examples of “illness” genes, their pathogenic effects on NMDA receptor activation and, when available, results of studies of impaired sociability in mouse models, including “proof of principle/proof of concept” experiments exploring NMDA receptor agonist interventions and the development of promising positive allosteric modulators (PAMs), which serve as support and models for developing an inventory of PAMs and negative allosteric modulators (NAMs) for translational therapeutic intervention. Conceivably, selective PAMs and NAMs either alone or in combination will be administered to patients guided by their genotype in order to potentiate and/or restore disrupted balance between activation mediated by GluN2B-subtype and GluN2A-subtype containing NMDA receptors.

28 October 2022 in Medical Clinics of North America
Verified
Journal Article
Closed access
SDStephen I. Deutsch
Stephen I. Deutsch
JBJessica Burket
Jessica Burket

4 October 2024 in Clinical Neuropharmacology
Verified
Journal Article
Open access
SDStephen I. Deutsch
Stephen I. Deutsch
JBJessica Burket
Jessica Burket
JEJeffrey Elikan
Jeffrey Elikan
DSDavid R. Spiegel
David R. Spiegel
Dostoyevsky's novels raise profound ethical, moral, philosophical and theological issues and, as a result, both he and his novels serve as fertile subjects of scholarly inquiry across a variety of academic disciplines. In particular, major characters in “The Brothers Karamazov” lend themselves to classical psychodynamic formulations, such as the influence of adverse childhood experiences on adult social and occupational outcomes, which in the case of Dmitry, the eldest son of Fyodor Pavlovich Karamazov, are considered in exquisitely fine detail. Prosecutor and defense attorney provide differing interpretations of how early traumas, largely due to paternal neglect and abuse, affected Dmitry's adult outcome in the climactic trial over his alleged patricide. The novel also captures an extreme, and perhaps fanciful, description of an Oedipal rivalry between Dmitry and his father for the affection of a love interest leading to tragic and unpredictable consequences for both. The novel has been dissected by scholars across a variety of diverse and seemingly unrelated disciplines and continues to serve as a springboard for collaborative discussion. Re-reading the novel led the authors to wonder if translational developments in clinical neuroscience could further understanding of poor developmental trajectories of the novel's characters, as well as offer therapeutic recommendations for promoting more favorable occupational and social outcomes. Advances in basic neuroscience have been translated into actionable individualized, interdisciplinary, multimodal treatment plans leading to improved functional outcomes for children like Dmitry, Ivan, and Smerdyakov. Translational neuroscience enriches understanding of neurodevelopmental outcomes of characters in Dostoyevsky's novel “The Brothers Karamazov,” especially in the context of genetic risk and in utero environmental insults.

31 July 2026 in Clinical Neuropharmacology
Verified
Journal Article
Closed access
SDStephen I. Deutsch
Stephen I. Deutsch
JEJeffrey Elikan
Jeffrey Elikan
DSDavid R. Spiegel
David R. Spiegel
MCMary-Caroline Cockerham
Mary-Caroline Cockerham
JBJessica Burket
Jessica Burket
Last of the Just, a novel of historical fiction published in 16 languages and recipient of France’s highest literary award, is recognized for its scholarly contribution to Holocaust education and conceptualization of the Lamid Vavnik, one of “36 (largely anonymous) Just Men of Jewish Tradition” responsible for sustaining humanity. The book’s main character is Ernie Levy, who has clinical manifestations of dissociation, psychosis, and an anesthetized tolerance of severe pain associated with repeated traumatic exposures to emotional and physical abuse. Clinical investigation of disordered personality structures with heightened sensitivity to dissociation and psychosis; episodes of dissociation and psychosis associated with traumatic exposures; and small numbers of community-dwelling adults endorsing frequent dissociation, whose characterization includes depersonalization and derealization, associated with histories of childhood abuse have probable explanatory relevance to Ernie’s presentation. Phencyclidine (PCP), an uncompetitive NMDA receptor antagonist, introduced into human medicine as a novel anesthetic agent precipitates dissociation and a schizophreniform psychosis in susceptible persons. D-Cycloserine (DCS), a partial NMDA receptor agonist, has been explored for several psychiatric indications in dosages with acceptable tolerability and safety. Adjunctive acute “time-limited” administration of DCS in conjunction with psychotherapy may contribute to mitigating severity and lessening duration of episodes of dissociation and psychosis associated with traumatic exposures. However, significant limitations of DCS exist and disappointing results of meta-analyses exploring effectiveness in a variety of psychiatric indications necessitate consideration of strategically targeted, single, or intermittent administration in conjunction with behavioral or cognitive-behavioral interventions. DCS may have a niche indication for a narrowly defined “dissociative” subtype of PTSD. More broadly, a selective review of literature suggests that insights gleaned from translational neuroscience can contribute, albeit modestly, to scholarly considerations in seemingly remote disciplines, such as history, literature, and theology.